Ran Reshef
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Transplantation top 2%
Papers in
- Oncology 86
- CAR-T cell therapy research 41
- Viral-associated cancers and disorders 24
- Polyomavirus and related diseases 17
- Hematology 50
- Hematopoietic Stem Cell Transplantation 39
- Co-authors
- David Porter (19 shared papers)Edward A. Stadtmauer (28 shared papers)Daniel F. Heitjan (9 shared papers)Robert H. Vonderheide (20 shared papers)Marlise R. Luskin (10 shared papers)Elizabeth O. Hexner (25 shared papers)Noelle V. Frey (23 shared papers)Donald E. Tsai (15 shared papers)
- Journals
- Blood (33 papers)Biology of Blood and Marrow Transplantation (20 papers)Journal of Clinical Oncology (14 papers)Transplantation and Cellular Therapy (8 papers)American Journal of Hematology (4 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Ran Reshef
134 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 94
- Hematology 620
- Transplantation 124
- Oncology 979
- Immunology 584
- Pathology and Forensic Medicine 303
Countries citing papers authored by Ran Reshef
This map shows the geographic impact of Ran Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Reshef more than expected).
Fields of papers citing papers by Ran Reshef
This network shows the impact of papers produced by Ran Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Reshef. The network helps show where Ran Reshef may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Reshef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 260 | |
| 2 | 2012 | 176 | |
| 3 | 2011 | 164 | |
| 4 | 2015 | 120 | |
| 5 | 2017 | 97 | |
| 6 | 2018 | 55 | |
| 7 | 2014 | 49 | |
| 8 | 2015 | 44 | |
| 9 | 2017 | 43 | |
| 10 | 2015 | 43 | |
| 11 | 2020 | 41 | |
| 12 | 2024 | 40 | |
| 13 | 2006 | 40 | |
| 14 | 2022 | 40 | |
| 15 | 2011 | 39 | |
| 16 | 2009 | 36 | |
| 17 | 2011 | 35 | |
| 18 | 2012 | 34 | |
| 19 | 2015 | 34 | |
| 20 | 2015 | 33 |
About Ran Reshef
Ran Reshef is a scholar working on Oncology, Hematology, Immunology, Pathology and Forensic Medicine and Genetics, having authored 142 papers that have together received 2.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (41 papers), Hematopoietic Stem Cell Transplantation (39 papers), Viral-associated cancers and disorders (24 papers), Lymphoma Diagnosis and Treatment (21 papers), Polyomavirus and related diseases (17 papers), Immune Cell Function and Interaction (16 papers), Cytomegalovirus and herpesvirus research (12 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Hematology (620 citations), Transplantation (124 citations), Oncology (979 citations), Immunology (584 citations) and Pathology and Forensic Medicine (303 citations). Ran Reshef has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include David Porter, Edward A. Stadtmauer, Daniel F. Heitjan, Robert H. Vonderheide, Marlise R. Luskin, Elizabeth O. Hexner, Noelle V. Frey, Donald E. Tsai, Alison W. Loren and Selina M. Luger. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Transplantation and Cellular Therapy and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.